Adverse drug reactions of antidepressants and antipsychotics: Experience, knowledge and attitudes among Norwegian psychiatrists
Authors:
- Ingrid CastbergICIngrid Castberg
- Arne ReimersARArne Reimers
- Pål SandvikPSPål Sandvik
- Trond O. AamoTATrond O. Aamo
- Olav SpigsetOSOlav Spigset
- 1 January 2006
- journal article
- Published by Taylor & Francis in Nordic Journal of Psychiatry
- Vol. 60 (3) , 227-233
Abstract
Efficient prevention of adverse drug reactions (ADRs) requires knowledge about their severity and pharmacological mechanisms and is dependent on reliable data on their frequencies and possible risk factors. The study was conducted to investigate the prescribers' experience and understanding of the ADRs of psychotropic drugs, and their attitude towards reporting these. In a questionnaire, physicians treating adult psychiatric patients were asked which ADRs that they regarded bothersome for some of the most widely used antidepressants and antipsychotics. Questions about the relationship between blockade of drug receptors and ADRs, and about the physicians' personal experience of and attitudes towards reporting of ADRs were also included. In total, 70 of 91 questionnaires (78%) were returned. The mean number of ADRs regarded bothersome ranged from 2.4 to 9.3 for the various drugs/drug classes. Qualified psychiatrists stated a significantly higher number of bothersome ADRs than did the residents. The percentage of physicians associating blockade of a receptor with a specific ADR varied from 76% (histamine receptor blockade and sedation) to 37% (alpha(1)-adrenergic blockade and tachycardia). Thirty-nine per cent of the physicians had never reported an ADR to the Norwegian Medicines Agency. The number of ADRs considered bothersome was relatively high. The pattern of these ADRs generally mirrored the typical ADR profiles of the drugs. The knowledge of the underlying mechanisms of ADRs was more or less incomplete. The reporting rate of ADRs to the national regulatory authorities was low.Keywords
This publication has 18 references indexed in Scilit:
- Incidence and Duration of Side Effects and Those Rated as Bothersome With Selective Serotonin Reuptake Inhibitor Treatment for DepressionThe Journal of Clinical Psychiatry, 2004
- Under‐reporting of serious adverse drug reactions in SwedenPharmacoepidemiology and Drug Safety, 2004
- Factors influencing the spontaneous reporting of adverse drug reactions—the experience of the Slovak RepublicPharmacoepidemiology and Drug Safety, 2003
- Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized TrialsAmerican Journal of Psychiatry, 2001
- Attitudinal survey of voluntary reporting of adverse drug reactionsBritish Journal of Clinical Pharmacology, 1999
- Spontaneous reporting of adverse drug reactions: who reports and what?Pharmacoepidemiology and Drug Safety, 1998
- Post-Approval Drug Research: Objectives and MethodsPharmacopsychiatry, 1997
- Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom [see comments]British Journal of Clinical Pharmacology, 1995
- Selective serotonin reuptake inhibitorsInternational Clinical Psychopharmacology, 1994
- Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.BMJ, 1993